Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection
Clinical trial NCT01273948 · COMPLETED
Trial details
- NCT number
- NCT01273948
- Sponsor
- Peregrine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-01-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.